Nephrology practices that are proactive rather than reactive provide better care at a lower cost, Stanford researchers find.
Results from a multi-center clinical trial show that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.
A kidney disease of unknown origin is sickening many men in Sri Lanka. Stanford researcher Shuchi Anand is working to understand it and to improve care.
Robbie Turner was only 28 years old when she was diagnosed with polycystic kidney disease — a genetic disorder that causes clumps of cysts to …
End-stage renal disease makes up 7.2 percent of Medicare spending, even though those patients represent less than 1 percent of the Medicare population, according to …
